Oxford-AstraZeneca Covid vaccine is 70% efficient, trial shows

A take a look at tube labelled vaccine is seen in entrance of AstraZeneca brand on this illustration taken, September 9, 2020.

Dado Ruvic | Reuters

LONDON — British pharmaceutical large AstraZeneca on Monday stated an interim evaluation of medical trials confirmed its coronavirus vaccine has a median efficacy of 70% in defending in opposition to the virus.

This is a breaking information story, please test again later.

Source hyperlink

What do you think?

Written by Business Boy


Leave a Reply

Your email address will not be published. Required fields are marked *



Hopes for a coronavirus vaccine are creating market winners — and losers

Germany looks set to extend lockdown into December as infections remain high